Detalhe da pesquisa
1.
Cost of adverse drug events related to potentially inappropriate medication use: A systematic review.
J Am Pharm Assoc (2003)
; 62(5): 1463-1476.e14, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513979
2.
Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review.
Res Social Adm Pharm
; 18(2): 2259-2268, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34144899
3.
Methodological quality and risk of bias of meta-analyses of pharmacy services: A systematic review.
Res Social Adm Pharm
; 18(3): 2403-2409, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358399
4.
Cost-Effectiveness of Molecular Method Diagnostic for Rapid Detection of Antibiotic-Resistant Bacteria.
Value Health Reg Issues
; 27: 12-20, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784543
5.
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE - Coalition V): A double-blind, multicentre, randomised, controlled trial.
Lancet Reg Health Am
; 11: 100243, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378952
6.
Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis.
Expert Opin Drug Saf
; 20(6): 735-740, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33641547
7.
Outcome measures for disease-modifying therapies in relapsing multiple sclerosis randomized clinical trials: a scoping review protocol.
JBI Evid Synth
; 18(8): 1781-1787, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898371
8.
Clinical pharmacy services in Brazil, particularly cardiometabolic diseases: a systematic scoping review and meta-analyses.
Pharm Pract (Granada)
; 18(4): 2131, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33294063
9.
Mapping the characteristics of meta-analyses of pharmacy services: a systematic review.
Int J Clin Pharm
; 42(5): 1252-1260, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32430882
10.
Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.
PLoS One
; 15(6): e0231722, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32544164
11.
Efficacy and safety of the pharmacotherapy used in the management of hyperkalemia: a systematic review.
Pharm Pract (Granada)
; 17(1): 1361, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31015873
12.
Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis.
Mult Scler Relat Disord
; 35: 7-15, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31276913
13.
Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis.
CNS Drugs
; 32(9): 813-826, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014314
14.
Genetic polymorphisms associated with upper gastrointestinal bleeding: a systematic review protocol
Rev. ciênc. farm. básica apl
; 4001/01/2019.
Artigo
em Inglês
| LILACS | ID: biblio-1100192
15.
Pharmacist-led interventions in Brazil: a scoping review protocol
Rev. ciênc. farm. básica apl
; 3901/01/2018.
Artigo
em Inglês
| LILACS | ID: biblio-1100199